Company Search:
Advanced Search
Sponsored Links
Lescarden, Inc. Company Snapshot
Lescarden, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lescarden with three other companies in this sector in the United States: Alder Biopharmaceuticals Inc (2016 sales of $113,000.00 of which 100% was Pharmaceutical Prep), Savara Inc ($128,000.00 of which 100% was Biomedical Research and Development), and Regen Biopharma Inc ($100,000.00 ).

Sales Analysis. Lescarden reported sales of $119,681.00 for the fiscal year ending May of 2016. This represents a sharp decrease of 52.7% versus 2015, when the company's sales were $253,045.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lescarden, Inc.
  Stock Performance Chart for Lescarden, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2018): .02
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks -57.1%  
Lescarden, Inc. Key Data:
  Ticker: LCAR Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 119,681
(Year Ending Jan 2017).
Employees: 1
  Currency: U.S. Dollars Market Cap: 954,335
  Fiscal Yr Ends: May Shares Outstanding: 63,622,316
  Share Type: Common Closely Held Shares: 47,662,378
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.